Tags

Type your tag names separated by a space and hit enter

[Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
Zhongguo Zhong Yao Za Zhi. 2020 Jul; 45(13):3001-3006.ZZ

Abstract

Coronavirus disease 2019(COVID-19) is a newly emerged and highly contagious respiratory disease. Traditional Chinese medicine(TCM) has both systematism theory knowledge and clinical practical value in the prevention and treatment of COVID-19. Therefore, it was particularly important to examine the effect of TCM in the prevention and treatment of COVID-19. The patents of TCM might reflect the latest progression of scientific research. We aimed to provide reference for the prevention and treatment of COVID-19 by extracting and analyzing the TCM patents from the Patent Information Sharing Platform of COVID-19. The antiviral TCM patents were screened and exported from the Patent Information Sharing Platform. VOSviewer 1.6.14 was used to visualize and analyze the network of TCM in these patents. There were total 292 TCM patents, including 52 patents for etiological treatment and 240 patents for symptomatic treatment. Thirty-two provinces and 1 076 inventors were involved, mainly from Beijing, Guangdong and Jiangsu. Overall, there were 356 TCMs, 71 single prescriptions, and 221 compound prescriptions. The patents for treatment of coronavirus mainly focused on the treatment of coronavirus, while the patents for symptomatic treatment mainly focuses on the improvement of respiratory symptoms, such as fever and cough. There were 14 highly frequently used TCMs, including Glycyrrhizae Radix et Rhizoma, Scutellariae Radix, Lonicerae Japonicae Flos, Forsythiae Fructus, Isatidis Radix, Astragali Radix, Menthae Haplocalycis Herba, Gypsum Fibrosum, Houttuyniae Herba, Isatidis Folium, Rhei Radix et Rhizoma, Gardeniae Fructus, Platycodonis Radix, Armeniacae Semen Amarum. The analyzed results of the TCM patents from the patent information sharing platform of COVID-19 were consistent with the Guideline of Diagnosis and Treatment of COVID-19(7th edition), and the combination of TCM in each cluster may also provide future directions for drug compatibility.

Authors+Show Affiliations

Evidence-based Nursing Center, School of Nursing, Lanzhou University Lanzhou 730000, China.Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University Lanzhou 730000, China.Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 300193, China.Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University Lanzhou 730000, China.Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University Lanzhou 730000, China.Evidence-based Nursing Center, School of Nursing, Lanzhou University Lanzhou 730000, China.Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 300193, China.Evidence-based Nursing Center, School of Nursing, Lanzhou University Lanzhou 730000, China Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University Lanzhou 730000, China.

Pub Type(s)

Journal Article

Language

chi

PubMed ID

32726004

Citation

Yang, Ke-Lu, et al. "[Analysis of Traditional Chinese Medicine From Patent Information Sharing Platform of Coronavirus Disease 2019 (COVID-19)]." Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, vol. 45, no. 13, 2020, pp. 3001-3006.
Yang KL, Gao Y, Yang FW, et al. [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)]. Zhongguo Zhong Yao Za Zhi. 2020;45(13):3001-3006.
Yang, K. L., Gao, Y., Yang, F. W., Liu, M., Shi, S. Z., Chen, Y. M., Zhang, J. H., & Tian, J. H. (2020). [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, 45(13), 3001-3006. https://doi.org/10.19540/j.cnki.cjcmm.20200330.501
Yang KL, et al. [Analysis of Traditional Chinese Medicine From Patent Information Sharing Platform of Coronavirus Disease 2019 (COVID-19)]. Zhongguo Zhong Yao Za Zhi. 2020;45(13):3001-3006. PubMed PMID: 32726004.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)]. AU - Yang,Ke-Lu, AU - Gao,Ya, AU - Yang,Feng-Wen, AU - Liu,Ming, AU - Shi,Shu-Zhen, AU - Chen,Ya-Min, AU - Zhang,Jun-Hua, AU - Tian,Jin-Hui, PY - 2020/7/30/entrez PY - 2020/7/30/pubmed PY - 2020/8/4/medline KW - 2019-nCoV KW - COVID-19 KW - patent KW - traditional Chinese medicine SP - 3001 EP - 3006 JF - Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica JO - Zhongguo Zhong Yao Za Zhi VL - 45 IS - 13 N2 - Coronavirus disease 2019(COVID-19) is a newly emerged and highly contagious respiratory disease. Traditional Chinese medicine(TCM) has both systematism theory knowledge and clinical practical value in the prevention and treatment of COVID-19. Therefore, it was particularly important to examine the effect of TCM in the prevention and treatment of COVID-19. The patents of TCM might reflect the latest progression of scientific research. We aimed to provide reference for the prevention and treatment of COVID-19 by extracting and analyzing the TCM patents from the Patent Information Sharing Platform of COVID-19. The antiviral TCM patents were screened and exported from the Patent Information Sharing Platform. VOSviewer 1.6.14 was used to visualize and analyze the network of TCM in these patents. There were total 292 TCM patents, including 52 patents for etiological treatment and 240 patents for symptomatic treatment. Thirty-two provinces and 1 076 inventors were involved, mainly from Beijing, Guangdong and Jiangsu. Overall, there were 356 TCMs, 71 single prescriptions, and 221 compound prescriptions. The patents for treatment of coronavirus mainly focused on the treatment of coronavirus, while the patents for symptomatic treatment mainly focuses on the improvement of respiratory symptoms, such as fever and cough. There were 14 highly frequently used TCMs, including Glycyrrhizae Radix et Rhizoma, Scutellariae Radix, Lonicerae Japonicae Flos, Forsythiae Fructus, Isatidis Radix, Astragali Radix, Menthae Haplocalycis Herba, Gypsum Fibrosum, Houttuyniae Herba, Isatidis Folium, Rhei Radix et Rhizoma, Gardeniae Fructus, Platycodonis Radix, Armeniacae Semen Amarum. The analyzed results of the TCM patents from the patent information sharing platform of COVID-19 were consistent with the Guideline of Diagnosis and Treatment of COVID-19(7th edition), and the combination of TCM in each cluster may also provide future directions for drug compatibility. SN - 1001-5302 UR - https://www.unboundmedicine.com/medline/citation/32726004/[Analysis_of_traditional_Chinese_medicine_from_patent_information_sharing_platform_of_coronavirus_disease_2019__COVID_19_]_ L2 - https://medlineplus.gov/coronavirusinfections.html DB - PRIME DP - Unbound Medicine ER -